News
Vantia Therapeutics appoints new CEO
9 June 2010
Vantia Therapeutics today announced that it has appointed Andrew Crockett to the position of Chief Executive Officer (CEO). more»
VA111913 structure revealed
26 March 2010
Vantia Therapeutics reveals structure of its novel small molecule treatment for dysmenorrhoea, VA111913, at the ACS National Meeting. more»
Contact Details
Vantia Therapeutics
Southampton Science Park
1 Venture Road
Chilworth
Southampton
SO16 7NP
United Kingdom
t +44 23 8076 3400
f +44 23 8076 6755
http://www.vantia.com
info@vantia.com
Business Development:
For enquiries about partnering programs with Vantia Therapeutics please contact bus.dev@vantia.com.
